2024

Peer-reviewed Publications

1. Pourafkari M, Connelly KA, Verma S, Mazer CD, Teoh H, Quan A, Goodman SG, Rai A, Ng MY, Deva DP, Triverio P, Juan LJ, Yan AT, Ge Y. Empagliflozin and left atrial function in patients with type 2 diabetes mellitus and coronary artery disease: Insight from the EMPA‐HEART CardioLink‐6 randomized clinical trial. Cardiovasc Diabetol. 2024 Aug 28;23(1):319.
2. Park B, Krishnaraj A, Teoh H, Bakbak E, Dennis F, Quan A, Hess DA, Verma S. GLP-1RA therapy increases circulating vascular regenerative cell content in people living with type 2 diabetes. Am J Physiol Heart Circ Physiol. 2024 Aug 1;327(2):H370-H376.
3. Bakbak E, Krishnaraj A, Bhatt DL, Quan A, Park B, Bakbak AI, Bari B, Terenzi KA, Pan Y, Fry EJ, Terenzi DC, Puar P, Khan TS, Rotstein OD, Mazer CD, Leiter LA, Teoh H, Hess DA, Verma S. Icosapent ethyl modulates circulating vascular regenerative cell content: The IPE-PREVENTION CardioLink-14 trial. Med. 2024 Jul 12;5(7):718-734.e4
4. Hibino M, Peterson MD, Tachibana R, Chu MWA, Bozinovski J, Dagenais F, Quan A, de Vasconcelos Papa F, Dickson J, Teoh H, Alli A, Hare GMT, Smith EE, Verma S, Mazer CD. Association of cerebral oximetry with brain ischemic lesions and functional outcomes in arch repair. Ann Thorac Surg. 2024 Mar;117(3):627-633.
5. Krishnaraj A, Bakbak E, Teoh H, Quan A, Pan Y, Firoz IN, Pandey AK, Terenzi DC, Verma R, Bari B, Bakbak AI, Padanilathu Kunjummar S, Yanagawa B, Connelly KA, Mazer CD, Butler J, Bhatt DL, McGuire DK, Hess DA, Verma S. Vascular regenerative cell deficiencies in South Asian adults. Results from the ORIGINS-RCE CardioLink-13 study. J Am Coll Cardiol. 2024 Feb 20;83(7):755-769.